BASF's new bioactive ingredient the wellness elixir for healthy skin

1 Oct 2019

The active ingredient is a 100% natural extract from the chaga mushroom, obtained using an innovative eco-friendly technology: subcritical water extraction.

Extracted from the chaga mushroom (Inonotus obliquus), native to the Northern Canadian forest, Inolixir is the most recent addition to BASF’s portfolio of bioactive ingredients. With its antioxidant and anti-inflammatory properties, it fortifies the skin’s natural protection system by strengthening barrier function and the microvascular network – working on all fronts to return skin to a healthier condition, with visible results on fine lines, dark-circles and redness.

BASF's new bioactive ingredient the wellness elixir for healthy skin

A superfood ingredient for healthy skin

The chaga mushroom is a superfood renowned for various health benefits and has both traditional and modern uses. With Inolixir (INCI: Glycerin (and) Water (and) Inonotus Obliquus (Mushroom) Extract), BASF scientists have now harnessed the chaga mushroom’s power for use in skin care products, catering to the worldwide consumer trend of changing perceptions of beauty and the increasing popularity of a more holistic approach. This often involves consumers making lifestyle changes and, importantly, looking for cosmetic products with natural ingredients.

A powerful, dual action bioactive ingredient offering quick and long-lasting results

Inolixir works in two ways: first, it offers a wellness approach proven to be effective on tired and stressed skin. Study participants reported that Inolixir was as effective as a 5-day relaxation cure in mitigating fatigue lines, dark circles and dullness. Second, the bioactive ingredient presents dermocosmetic solutions for sensitive skin: it offers anti-redness and anti-dullness benefits, leading 85% of study participants to perceive a health benefit for their skin and 91% to report increased skin comfort within 7 to 28 days of application.

Inolixir is a hyper-concentrated bioactive ingredient, benefitting from all the nutrients and properties of the chaga mushroom thanks to an innovative and eco-friendly technology: subcritical water extraction (SWE). Instead of organic solvents, this method uses pressurized water heated to between 100 °C and 374 °C for extraction. In vitro tests have proven that SWE extracts phytochemicals more efficiently than other common methods, such as conventional hydroethanolic extraction and water extraction.

Read More

Related news

GSK partners with Samsung Biologics to secure additional manufacturing capacity

GSK partners with Samsung Biologics to secure additional manufacturing capacity

26 May 2020

The agreement will initially cover the commercial production of Benlysta (belimumab) with the intention to expand to additional specialty-care products in the future.

Read more 
Changes needed to prevent controversial pay-for-delay pharma deals

Changes needed to prevent controversial pay-for-delay pharma deals

26 May 2020

Researchers endorse a switch from the current first-filer system in the US to a system that instead rewards the first successful challenger.

Read more 
SeraNova and Carna Biosciences to develop oral formulation of a new active ingredient

SeraNova and Carna Biosciences to develop oral formulation of a new active ingredient

26 May 2020

SeraNovo enters into a second license agreement with Carna Biosciences for development of oral formulation of Carna’s kinase inhibitor.

Read more 
AbCellera and Lilly seal multi-year antibody discovery collaboration

AbCellera and Lilly seal multi-year antibody discovery collaboration

25 May 2020

AbCellera, will use its antibody drug discovery platform to identify antibodies against up to nine targets.

Read more 
HKBU invents nanostructure that stimulates growth of stem cells for Parkinson's treatment

HKBU invents nanostructure that stimulates growth of stem cells for Parkinson's treatment

25 May 2020

The invention could pave the way for treatments to cure Parkinson's and Alzheimer's disease.

Read more 
Can the industry really claim it's 'business as usual'?

Can the industry really claim it's 'business as usual'?

19 May 2020

ChargePoint Technology's Chief Commercial Officer says "yes" it can.

Read more 
HKBU scientists develop technique to eliminate drug side effects

HKBU scientists develop technique to eliminate drug side effects

19 May 2020

The novel method paves the way towards the mass production of affordable therapeutic drugs that are made with recyclable materials.

Read more 
Samsung Biologics expands business continuity excellence with additional ISO 22301 certification

Samsung Biologics expands business continuity excellence with additional ISO 22301 certification

19 May 2020

The certification is expected to instill greater 'supply' trust with clients, particularly during the current pandemic.

Read more 
Vibalogics agrees to additional manufacturing for lead COVID-19 vaccine candidate of J&J unit

Vibalogics agrees to additional manufacturing for lead COVID-19 vaccine candidate of J&J unit

18 May 2020

CDMO is contracted to produce multiple clinical batches from German facility

Read more 
Pharmapack expert recommends holistic approach to sustainability

Pharmapack expert recommends holistic approach to sustainability

18 May 2020

Although the industry might be 30% along its sustainability journey, greater interoperability is needed from materials to devices.

Read more